Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
Memo Therapeutics is a biotechnology research company that engages in antibody discovery and immune repertoire analysis.
Multiverse is the upskilling platform for AI and Tech adoption.
Araris Biotech is a biotechnology company that develops antibody-drug conjugates for efficient payload attachment.
Healthy Workers makes employee well-being measurable.
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Luminance provides an AI-powered platform for contract generation, negotiation, and post-execution analysis using legal-focused models.
Somagenetix is a new firm that wants to be a leader in gene therapy by developing first-in-class treatments for phagocyte-related illnesses.
iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.
tem is building the new transactions infrastructure for a modern energy market to provide universal access to the lowest-cost electricity.
Fastned is a fast-charging network for electric vehicles to charge with renewable energy from the sun and wind.
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
Vantage Data Centers designs and develops data center campuses to large cloud providers, AI enterprises, and other tech-driven businesses.
AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.
Cera is Europe’s largest provider of digital-first home healthcare
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Poolside is an artificial intelligence platform that offers foundation concepts and infrastructure to write software codes.
Wayve develops autonomous driving technology using end-to-end deep learning models that enable vehicles to navigate urban environments.
AgroStar is an agritech company that offers agribusiness farming, rural e-commerce and retail services.
Schroders Capital has invested in 40 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Schroders Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Artificial Intelligence (AI). The firm invests across 54 different industry categories.
Among tracked funding rounds, Wayve received $1.2B in a Series D round. Schroders Capital's total known invested capital is $3.9B.
Schroders Capital's average investment size is $107.2M across its portfolio of 40 companies.
Recent Schroders Capital portfolio additions include Epsilogen, HAYA Therapeutics, Memo Therapeutics, Multiverse, Araris Biotech. These companies were founded in 2020 or later.